Send to

Choose Destination


See: Retraction Notice

Mol Cells. 2005 Feb 28;19(1):46-53.

Efficient derivation of new human embryonic stem cell lines.

Author information

Division of Stem Cell Biology, Medical Research Center, MizMedi Hospital, Seoul 157-280, Korea.

Retraction in


Human embryonic stem (hES) cells, unlike most cells derived from adult or fetal human tissues, represent a potentially unlimited source of various cell types for basic clinical research. To meet the increased demand for characterized hES cell lines, we established and characterized nine new lines obtained from frozen-thawed pronucleus-stage embryos. In addition, we improved the derivation efficiency from inner cell masses (to 47.4%) and optimized culture conditions for undifferentiated hES cells. After these cell lines had been maintained for over a year in vitro, they were characterized comprehensively for expression of markers of undifferentiated hES cells, karyotype, and in vitro/in vivo differentiation capacity. All of the cell lines were pluripotent, and one cell line was trisomic for chromosome 3. Improved culture techniques for hES cells should make them a good source for diverse applications in regenerative medicine, but further investigation is needed of their basic biology.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Publishing M2Community
Loading ...
Support Center